-
1.发明公开INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID 审中-公开磺烷基醚环糊精和皮质类固醇物质含有吸入制剂
公开(公告)号：EP2043599A4
公开(公告)日：2011-06-29
申请号：EP06850326
申请日：2006-12-19
CPC分类号： A61K47/61 , A61K9/0078 , A61K31/573 , A61K31/58 , A61K31/724 , A61K45/06 , A61K47/40 , A61K47/48092 , A61K47/6951 , B82Y5/00 , C08B37/0015 , C08L5/16 , A61K2300/00
摘要： An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus.
-
2.发明公开NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS 有权鼻腔和眼部给药水性CORTICOSTEROIDLÖSUNGEN的
公开(公告)号：EP2173169A4
公开(公告)日：2010-08-04
申请号：EP08781216
申请日：2008-06-30
IPC分类号： A01N43/04 , A61K31/715
CPC分类号： A61K31/55 , A61K9/0043 , A61K9/0048 , A61K9/08 , A61K31/335 , A61K31/506 , A61K31/56 , A61K31/57 , A61K31/58 , A61K31/715 , A61K31/724 , A61K45/06 , A61K47/40 , A61M31/00 , A61K2300/00
-
公开(公告)号：EP1755551A4
公开(公告)日：2010-04-21
申请号：EP05743067
申请日：2005-04-22
CPC分类号： A61K47/40 , A61K9/0075 , Y10T428/2982
-
-
搜索结果
3 条记录 (耗时 0.006 秒)
